ロード中...
A review of the safety and efficacy of nebivolol in the mildly hypertensive patient
Nebivolol is a third generation beta-blocker, which can be distinguished from other beta-blockers by its hemodynamic profile. It combines beta-adrenergic blocking activity with a vasodilating effect mediated by the endothelial L-arginine nitric oxide (NO) pathway. The effects of nebivolol have been...
保存先:
| 第一著者: | |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove Medical Press
2007
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2350132/ https://ncbi.nlm.nih.gov/pubmed/18200810 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|